BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34519021)

  • 21. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
    Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.
    Arcaini L; Varettoni M; Boveri E; Orlandi E; Rattotti S; Zibellini S; Merli M; Lucioni M; Rizzi S; Gotti M; Morello L; Pascutto C; Paulli M
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):103-5. PubMed ID: 21454204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenic marginal zone lymphoma: A US population-based survival analysis (1999-2016).
    Florindez JA; Alderuccio JP; Reis IM; Lossos IS
    Cancer; 2020 Nov; 126(21):4706-4716. PubMed ID: 32767702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden.
    Sima A; Hollander P; Baecklund E; Smedby KE; Enblad G; Amini RM
    Br J Haematol; 2021 Aug; 194(3):568-579. PubMed ID: 34109612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases.
    Montalbán C; Abraira V; Arcaini L; Domingo-Domenech E; Guisado-Vasco P; Iannitto E; Mollejo M; Matutes E; Ferreri A; Salar A; Rattotti S; Carpaneto A; Pérez Fernández R; Bello JL; Hernández M; Caballero D; Carbonell F; Piris MA;
    Br J Haematol; 2012 Oct; 159(2):164-71. PubMed ID: 22924582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk-tailored treatment of splenic marginal zone lymphoma.
    Castelli R; Balzarotti M; Salvi E; Simona Rossi R; Lambertenghi Deliliers G; Bergamaschini L; Gidaro A
    Anticancer Drugs; 2022 Jan; 33(1):e36-e42. PubMed ID: 34407041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection.
    Yu SC; Lin CW
    Kaohsiung J Med Sci; 2013 Mar; 29(3):150-6. PubMed ID: 23465418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma.
    Munari E; Rinaldi M; Ambrosetti A; Bonifacio M; Bonalumi A; Chilosi M; Zamò A
    Virchows Arch; 2012 Dec; 461(6):677-85. PubMed ID: 23064660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus infection and locally advanced splenic marginal zone lymphoma.
    Szynglarewicz B; Matkowski R; Smorag Z; Forgacz J; Pudelko M; Kornafel J
    Pathol Oncol Res; 2007; 13(4):382-4. PubMed ID: 18158578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
    Maeshima AM; Taniguchi H; Toyoda K; Yamauchi N; Makita S; Fukuhara S; Munakata W; Maruyama D; Kobayashi Y; Tobinai K
    Br J Haematol; 2016 Sep; 174(6):923-31. PubMed ID: 27460179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splenic marginal zone lymphoma: a case report and literature review.
    Zhang S; Xuan Z; Zhang L; Lu J; Song P; Zheng S
    World J Surg Oncol; 2020 Oct; 18(1):259. PubMed ID: 33004051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pathogenesis of splenic and nodal marginal zone lymphoma.
    Spina V; Rossi D
    Best Pract Res Clin Haematol; 2017; 30(1-2):5-12. PubMed ID: 28288716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
    Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
    Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal cytogenetic abnormalities are predictor in developing non-Hodgkin lymphomas?
    Wang Y; Xiao Y; Meng X; Zhang H; Li Q; Meng F; Huang L; Li C; Zhou J
    Exp Mol Pathol; 2017 Feb; 102(1):146-155. PubMed ID: 28087391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
    Xing KH; Kahlon A; Skinnider BF; Connors JM; Gascoyne RD; Sehn LH; Savage KJ; Slack GW; Shenkier TN; Klasa R; Gerrie AS; Villa D
    Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The prognostic significance of POD24 in 106 cases with splenic marginal lymphoma with bone marrow invasion].
    Lyu R; Yan YT; Yi SH; Wang TY; Deng SH; Liu W; Huang WY; An G; Sui WW; Zou DH; Qiu LG; Li ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):228-233. PubMed ID: 32311893
    [No Abstract]   [Full Text] [Related]  

  • 39. Splenic lymphoproliferative disorders in human T lymphotropic virus type-I endemic area of japan: clinicopathological, immunohistochemical and genetic analysis of 27 cases.
    Kumagawa M; Suzumiya J; Ohshima K; Kanda M; Tamura K; Kikuchi M
    Leuk Lymphoma; 2001 May; 41(5-6):593-605. PubMed ID: 11378577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
    Iannitto E; Bellei M; Amorim S; Ferreri AJM; Marcheselli L; Cesaretti M; Haioun C; Mancuso S; Bouabdallah K; Gressin R; Tripodo C; Traverse-Glehen A; Baseggio L; Zupo S; Stelitano C; Castagnari B; Patti C; Alvarez I; Liberati AM; Merli M; Gini G; Cabras MG; Dupuis J; Tessoulin B; Perrot A; Re F; Palombi F; Gulino A; Zucca E; Federico M; Thieblemont C
    Br J Haematol; 2018 Dec; 183(5):755-765. PubMed ID: 30407629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.